115 related articles for article (PubMed ID: 36260268)
1. Bioinformatic and Experimental Analyses Reveal That KIF4A Is a Biomarker of Therapeutic Sensitivity and Predicts Prognosis in Cervical Cancer Patients.
Wu J; Li L; Zhong H; Zhang HH; Li J; Zhang HB; Zhao YQ; Xu B; Song QB
Curr Med Sci; 2022 Dec; 42(6):1273-1284. PubMed ID: 36260268
[TBL] [Abstract][Full Text] [Related]
2. KIF4A Regulates the Progression of Pancreatic Ductal Adenocarcinoma through Proliferation and Invasion.
Chen J; Zhao CC; Chen FR; Feng GW; Luo F; Jiang T
Biomed Res Int; 2021; 2021():8249293. PubMed ID: 34805404
[TBL] [Abstract][Full Text] [Related]
3. KIF4A as a novel prognostic biomarker in cholangiocarcinoma.
Zhang DY; Ma SS; Sun WL; Lv XCH; Lu Z
Medicine (Baltimore); 2021 May; 100(21):e26130. PubMed ID: 34032761
[TBL] [Abstract][Full Text] [Related]
4. Upregulate KIF4A Enhances Proliferation, Invasion of Hepatocellular Carcinoma and Indicates poor prognosis Across Human Cancer Types.
Hou G; Dong C; Dong Z; Liu G; Xu H; Chen L; Liu L; Wang H; Zhou W
Sci Rep; 2017 Jun; 7(1):4148. PubMed ID: 28646197
[TBL] [Abstract][Full Text] [Related]
5. KIF4A: A potential biomarker for prediction and prognostic of prostate cancer.
Chen J; Li M; Fang S; Zhou X; Liao J; Yang S; Zhu J; He R; Lu J; Jiang F; Xu X; Zhong W
Clin Invest Med; 2020 Sep; 43(3):E49-59. PubMed ID: 32971585
[TBL] [Abstract][Full Text] [Related]
6. Prognostic Value and Immune-Infiltration Pattern of
Yang Z; Shen X; Luo S; Li Y
Dis Markers; 2022; 2022():9621701. PubMed ID: 35126794
[TBL] [Abstract][Full Text] [Related]
7. Identification of KIF4A and its effect on the progression of lung adenocarcinoma based on the bioinformatics analysis.
Song Y; Tang W; Li H
Biosci Rep; 2021 Jan; 41(1):. PubMed ID: 33398330
[TBL] [Abstract][Full Text] [Related]
8. Identification of KIF4A as a prognostic biomarker for esophageal squamous cell carcinoma.
Wang L; Liu G; Bolor-Erdene E; Li Q; Mei Y; Zhou L
Aging (Albany NY); 2021 Nov; 13(21):24050-24070. PubMed ID: 34775374
[TBL] [Abstract][Full Text] [Related]
9. Activation of KIF4A as a prognostic biomarker and therapeutic target for lung cancer.
Taniwaki M; Takano A; Ishikawa N; Yasui W; Inai K; Nishimura H; Tsuchiya E; Kohno N; Nakamura Y; Daigo Y
Clin Cancer Res; 2007 Nov; 13(22 Pt 1):6624-31. PubMed ID: 18006763
[TBL] [Abstract][Full Text] [Related]
10. KIF4A promotes genomic stability and progression of endometrial cancer through regulation of TPX2 protein degradation.
Zhang J; An L; Zhao R; Shi R; Zhou X; Wei S; Zhang Q; Zhang T; Feng D; Yu Z; Wang H
Mol Carcinog; 2023 Mar; 62(3):303-318. PubMed ID: 36468837
[TBL] [Abstract][Full Text] [Related]
11. KIF4A promotes the development of bladder cancer by transcriptionally activating the expression of CDCA3.
Zheng P; Wu K; Gao Z; Li H; Li W; Wang X; Shi Z; Xiao F; Wang K; Li Z; Han Q
Int J Mol Med; 2021 Jun; 47(6):. PubMed ID: 33846765
[TBL] [Abstract][Full Text] [Related]
12. miR-29c-3p regulates proliferation and migration in ovarian cancer by targeting KIF4A.
Feng S; Luo S; Ji C; Shi J
World J Surg Oncol; 2020 Dec; 18(1):315. PubMed ID: 33261630
[TBL] [Abstract][Full Text] [Related]
13. KIF4A facilitates cell proliferation via induction of p21-mediated cell cycle progression and promotes metastasis in colorectal cancer.
Hou PF; Jiang T; Chen F; Shi PC; Li HQ; Bai J; Song J
Cell Death Dis; 2018 May; 9(5):477. PubMed ID: 29706624
[TBL] [Abstract][Full Text] [Related]
14. Upregulation of kinesin family member 4A enhanced cell proliferation via activation of Akt signaling and predicted a poor prognosis in hepatocellular carcinoma.
Huang Y; Wang H; Lian Y; Wu X; Zhou L; Wang J; Deng M; Huang Y
Cell Death Dis; 2018 Feb; 9(2):141. PubMed ID: 29396392
[TBL] [Abstract][Full Text] [Related]
15. FOXM1 promotes hepatocellular carcinoma progression by regulating KIF4A expression.
Hu G; Yan Z; Zhang C; Cheng M; Yan Y; Wang Y; Deng L; Lu Q; Luo S
J Exp Clin Cancer Res; 2019 May; 38(1):188. PubMed ID: 31072351
[TBL] [Abstract][Full Text] [Related]
16. KIF4A enhanced cell proliferation and migration via Hippo signaling and predicted a poor prognosis in esophageal squamous cell carcinoma.
Sun X; Chen P; Chen X; Yang W; Chen X; Zhou W; Huang D; Cheng Y
Thorac Cancer; 2021 Feb; 12(4):512-524. PubMed ID: 33350074
[TBL] [Abstract][Full Text] [Related]
17. Enhanced expression of KIF4A in osteosarcoma predicts a poor prognosis and facilitates tumor growth by activation of the MAPK pathway.
Zhu D; Xu X; Zhang M; Wang T
Exp Ther Med; 2021 Nov; 22(5):1339. PubMed ID: 34630693
[TBL] [Abstract][Full Text] [Related]
18. Developing a 5-gene prognostic signature for cervical cancer by integrating mRNA and copy number variations.
Liu W; Jiang Q; Sun C; Liu S; Zhao Z; Wu D
BMC Cancer; 2022 Feb; 22(1):192. PubMed ID: 35184747
[TBL] [Abstract][Full Text] [Related]
19. Enhanced expression of KIF4A in colorectal cancer is associated with lymph node metastasis.
Matsumoto Y; Saito M; Saito K; Kanke Y; Watanabe Y; Onozawa H; Hayase S; Sakamoto W; Ishigame T; Momma T; Kumamoto K; Ohki S; Takenoshita S
Oncol Lett; 2018 Feb; 15(2):2188-2194. PubMed ID: 29434924
[TBL] [Abstract][Full Text] [Related]
20. YAP/TEAD4-induced KIF4A contributes to the progression and worse prognosis of esophageal squamous cell carcinoma.
Li Y; Zhu X; Yang M; Wang Y; Li J; Fang J; Guo W; Ma S; Guan F
Mol Carcinog; 2021 Jul; 60(7):440-454. PubMed ID: 34003522
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
